Clinical
New clinical trial registered for 177Lu-PSMA-617 (Extended Indications)
Related compound: 177Lu-PSMA-617 (Extended Indications)View source →
A Real-world Study of Characteristics, Treatment Patterns, and Clinical Outcomes Among Lutetium-177 Vipivotide Tetraxetan Treated Patients (NCT07477756) registered on ClinicalTrials.gov. Phase: Not specified. Status: completed.